Target intelligence / Profile preview

X-ray repair cross-complementing protein 6 (Ku70) (Ku70)

Target
Ku70
Molecular classification
DNA-binding protein, Enzyme, Transcription factor, DNA-dependent protein kinase subunit
01

Overview

X-ray repair cross-complementing protein 6, commonly known as Ku70, is a pivotal DNA-binding protein that forms a heterodimer with Ku80 to initiate the non-homologous end joining (NHEJ) pathway, the primary mechanism for repairing DNA double-strand breaks in mammalian cells [1, 11]. The Ku70/80 complex functions as a molecular scaffold that rapidly recognizes and binds to broken DNA ends, subsequently recruiting the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and other repair factors [2, 14]. Beyond its central role in maintaining genomic integrity, Ku70 is involved in telomere protection, Bax-mediated apoptosis, and acts as a cytosolic DNA sensor that triggers innate immune responses [4, 5]. In the context of oncology, Ku70 is often upregulated in various tumors, where it contributes to therapeutic resistance by efficiently repairing damage caused by ionizing radiation and chemotherapeutic agents [7, 15]. This has led to the development of small-molecule inhibitors, such as STL127705 and UMI-77, which aim to disrupt Ku-DNA interactions and sensitize cancer cells to DNA-damaging therapies [23, 29]. However, therapeutic targeting of Ku70 is complicated by its essential role in normal cell survival and its requirement for V(D)J recombination during immune system development [16, 27]. Additionally, Ku70 is a known autoantigen in systemic autoimmune diseases like lupus and polymyositis, further highlighting its complex biological significance [1, 11].

Other names
XRCC6G22P1Lupus Ku autoantigen protein p70ATP-dependent DNA helicase 2 subunit 1CTC75CTCBFML8TLAA
02

Mechanism of action

Inhibition of Ku-DNA binding and disruption of the Ku70/80 heterodimer to block non-homologous end joining (NHEJ) and sensitize cells to DNA-damaging agents.

03

Biological functions

DNA repairNon-homologous end joiningTelomere maintenanceApoptosisInnate immune responseCell cycle regulation
04

Disease associations

CancerAutoimmune diseaseInfectionAging-related disease
05

Safety considerations

Systemic toxicity due to DNA repair inhibitionImmunodeficiencyRisk of secondary malignanciesAutoimmune reactions
06

Interacting drugs

STL127705

5 more in the full profile.

07

Biomarkers

Ku70 expression levelKu70 acetylation statusCytoplasmic Ku70 localization

Beyond the preview

Go deeper on X-ray repair cross-complementing protein 6 (Ku70) (Ku70).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-ray repair cross-complementing protein 6 (Ku70) (Ku70).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call